Clinical Trial Update: Study to Evaluate the Safety and Tolerability of EP0042 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and tolerability of EP0042 from Ellipses Pharma is currently recruiting for acute myeloid leukemia, chronic myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• EP0042

Snippet

Sponsor: Ellipses Pharma | Conditions: Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 1, Phase 2 | Status: RECRUITING